Filing metadata

Accession number
0001209191-22-054838
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Oct 28, 2022
Reporting period
Oct 26, 2022
Description
Insider transaction

Explore SEC Filings Hub